Long-term response of pituitary carcinoma to temozolomide. Report of two cases

Journal of Neurosurgery

Volumn 105, Issue 4, 2006, Pages 621-626

  Fadul, Camilo E ^a   Kominsky, Andrew L ^b   Meyer, Louise P ^b   Kingman, Linda S ^b   Kinlaw, William B ^b   Rhodes, C Harker ^b   Eskey, Clifford J ^b   Simmons, Nathan E ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b NONE

Author keywords

Chemotherapy; Pituitary carcinoma; Temozolomide

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; BROMOCRIPTINE; CABERGOLINE; CARBOPLATIN; ETOPOSIDE; IODINE 131; OCTREOTIDE; PACLITAXEL; PEGINTERFERON; TEMOZOLOMIDE;

ADULT; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOMA; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CRANIOTOMY; DRUG RESPONSE; FATIGUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPROLACTINEMIA; HYPOPHYSIS CARCINOMA; HYPOPHYSIS TUMOR; LYMPHOCYTOPENIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINE METASTASIS; VISUAL IMPAIRMENT;

ADENOMA; ADULT; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; LUTEINIZING HORMONE; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; PROLACTINOMA; RADIOSURGERY; RETREATMENT; SPINAL CORD; SPINAL CORD NEOPLASMS; TREATMENT FAILURE;

EID: 33749537681     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.105.4.621     Document Type: Article

References (16)

1. Gaffey TA, Scheithauer BW, Lloyd RV, Burger PC, Robbins P, Fereidooni F, et al: Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four cases. J Neurosurg 96:352-360, 2002
2. Glantz M, Chamberlain M, Liu Q, Litofsky NS, Recht LD: Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97:2262-2266, 2003
3. Gollard R, Kosty M, Cheney C, Copeland B, Bordin G: Prolactin-secreting pituitary carcinoma with implants in the cheek pouch and metastases to the ovaries. A case report and literature review. Cancer 76:1814-1820, 1995
4. Jones SF, Gian VG, Greco FA, Miranda FT, Shipley DL, Thompson DS, et al: Phase I. Trial of irinotecan and temozolomide in patients with solid tumors. Oncology (Williston Park) 17:41-45, 2003
5. McCutcheon IE, Pieper DR, Fuller GN, Benjamin RS, Friend KE, Gagel RF: Pituitary carcinoma containing gonadotropins: treatment by radical excision and cytotoxic chemotherapy: case report. Neurosurgery 46:1233-1240, 2000
6. Molitch ME, Russell EJ: The pituitary "incidentaloma." Ann Intern Med 112:925-931, 1990
7. Moore MJ, Feld R, Hedley D, Oza A, Siu LL: A phase II study of temozolomide in advanced untreated pancreatic cancer. Invest New Drugs 16:77-79, 1998
8. Park DK, Ryan CW, Dolan ME, Vogelzang NJ, Stadler WM: A phase II trial of oral temozolomide in patients with metastatic renal cell cancer. Cancer Chemother Pharmacol 50:160-162, 2002
9. Pernicone PJ, Scheithauer BW, Sebo TJ, Kovacs KT, Horvath E, Young WF Jr, et al: Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79:804-812, 1997
10. Petterson T, MacFarlane IA, MacKenzie JM, Shaw MD: Prolactin secreting pituitary carcinoma. J Neurol Neurosurg Psychiatry 55:1205-1206, 1992
11. Ragel BT, Couldwell WT: Pituitary carcinoma: a review of the literature. Neurosurg Focus 16 (4):E7, 2004
12. Raymond E, Izbicka E, Soda H, Gerson SL, Dugan M, Von Hoff DD: Activity of temozolomide against human tumor colony-forming units. Clin Cancer Res 3:1769-1774, 1997
13. Scheithauer BW, Randall RV, Laws ER Jr, Kovacs KT, Horvath E, Whitaker MD: Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases. Cancer 55:598-604, 1985
14. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, et al: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20:1375-1382, 2002
15. Stupp R, Newlands E: New approaches for temozolomide therapy: use in newly diagnosed glioma. Semin Oncol 28 (Suppl 13):19-23, 2001
16. Trent JC, Beach J, Burgess MA, Papadopolous N, Chen LL, Benjamin RS, et al: A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas. Cancer 98:2693-2699, 2003